Legal Representation
Attorney
Ian W. Gillies
USPTO Deadlines
Next Renewal Deadline
784 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2021-08-31)
Due Date
August 31, 2027
Grace Period Ends
February 29, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
29 eventsDate | Code | Type | Description |
---|---|---|---|
Aug 31, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Jul 29, 2021 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Jul 28, 2021 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Jul 8, 2021 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Jul 7, 2021 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Jun 25, 2021 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Jun 25, 2021 | IUAF | S | USE AMENDMENT FILED |
May 13, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
May 11, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
May 11, 2021 | EXT2 | S | SOU EXTENSION 2 FILED |
May 11, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED |
Nov 11, 2020 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
Nov 9, 2020 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
Nov 9, 2020 | EXT1 | S | SOU EXTENSION 1 FILED |
Nov 9, 2020 | EX1G | S | SOU EXTENSION 1 GRANTED |
May 12, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Mar 17, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION |
Mar 17, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Feb 26, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Feb 11, 2020 | ALIE | A | ASSIGNED TO LIE |
Feb 5, 2020 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
Feb 5, 2020 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
Feb 5, 2020 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Feb 5, 2020 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
Feb 5, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jan 29, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
Oct 31, 2019 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED |
Oct 30, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Oct 28, 2019 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 001
Reagents used for scientific and research use; reagents, namely, antibodies and antibody fragments for scientific and research use
First Use Anywhere:
Jun 30, 2005
First Use in Commerce:
Jun 30, 2005
Class 005
Drugs, pharmaceuticals, cell preparations, vaccines and vaccine adjuvants, therapeutic antibodies and other reagents used in the diagnosis, prevention, monitoring and treatment of disease or disorders, namely, for cancer, infectious diseases, transplantation, inflammation and immune disorders
First Use Anywhere:
Jun 30, 2005
First Use in Commerce:
Jun 30, 2005
Class 042
Medical and scientific research and development, namely, screening, evaluation, development and conducting clinical trials of therapeutic, preventative and diagnostic compositions and treatments; research in the fields of biochemistry, biotechnology, and clinical trials; pharmaceutical research and development; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials via the internet
First Use Anywhere:
Jun 30, 2005
First Use in Commerce:
Jun 30, 2005
Additional Information
Design Mark
The mark consists of two overlapping circles and an irregular oval shape within and to the left of the two circles.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
001
005
042